Development of post-COVID-19 cardiovascular events: an analysis of clinical features and risk factors from a single hospital retrospective study.
COVID-19
SARS-CoV-2
cardiovascular diseases
Journal
Le infezioni in medicina
ISSN: 2532-8689
Titre abrégé: Infez Med
Pays: Italy
ID NLM: 9613961
Informations de publication
Date de publication:
2021
2021
Historique:
received:
22
09
2021
accepted:
10
11
2021
entrez:
11
2
2022
pubmed:
12
2
2022
medline:
12
2
2022
Statut:
epublish
Résumé
Cardiovascular complications after a SARS-CoV-2 infection are a phenomenon of relevant scientific interest. The aim of this study was to analyze the onset of post-COVID-19 cardiovascular events in patients hospitalized in a tertiary care center. This is a retrospective study conducted on patients hospitalized over a period of three months. The patients were older than 18 years of age and had a diagnosis of COVID-19 infection confirmed from a nasopharyngeal swab sample. Anamnestic and clinical-laboratory data were collected. Cardiovascular events at 30 days were defined as follows: arrhythmias, myocardial infarction, myocarditis, and pulmonary embolism. Univariate analysis (Student's t-test or Mann-Whitney U test, as appropriate) and multivariate analysis (multinomial logistic regression) were applied to the data. A total of 394 patients were included; they were mostly males and had a median age of 65.5 years. Previous cardiovascular disease was present in 14.7% of patients. Oxygen therapy was required for 77.9%, and 53% received anticoagulant therapy. The overall 30-day mortality was 20.3%. A cardiovascular event developed in 15.7% of the subjects. These were mainly pulmonary embolism (9.4%), followed by arrhythmias (3.3%), myocardial infarction (2.3%), and myocarditis (0.8%). Patients who developed cardiovascular events upon univariate analysis were significantly older, with major comorbidities, a more compromised respiratory situation, and a higher mortality rate. Multivariate analysis revealed independent factors that were significantly associated with the development of cardiovascular events: hypertension, endotracheal intubation, and age older than 75 years. In patients with COVID-19, the development of a cardiovascular event occurs quite frequently and is mainly seen in elderly subjects with comorbidities (especially hypertension) in the presence of a severe respiratory picture.
Identifiants
pubmed: 35146362
doi: 10.53854/liim-2904-6
pii: 1124-9390_29_4_2021_538-549
pmc: PMC8805477
doi:
Types de publication
Journal Article
Langues
eng
Pagination
538-549Informations de copyright
Copyright © 2016 - 2021 InfezMed.
Déclaration de conflit d'intérêts
Competing interests The authors declare that they have no competing interests.
Références
J Cardiovasc Electrophysiol. 2020 May;31(5):1003-1008
pubmed: 32270559
HIV AIDS (Auckl). 2016 Oct 31;8:175-182
pubmed: 27843352
Eur Heart J. 2021 Jan 7;42(2):206
pubmed: 32176300
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Int J Environ Res Public Health. 2020 Jul 14;17(14):
pubmed: 32674450
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Infez Med. 2021 Mar 1;29(1):1-9
pubmed: 33664168
J Infect Dev Ctries. 2020 Feb 29;14(2):125-128
pubmed: 32146445
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
J Cardiol. 2020 Nov;76(5):453-458
pubmed: 32736906
Prog Cardiovasc Dis. 2020 May - Jun;63(3):390-391
pubmed: 32169400
Thromb Haemost. 2020 Jun;120(6):998-1000
pubmed: 32316063
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
JAMA. 2020 Apr 21;323(15):1499-1500
pubmed: 32159735
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
Eur J Intern Med. 2020 Dec;82:29-37
pubmed: 32958372
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Clin Res Cardiol. 2020 May;109(5):531-538
pubmed: 32161990
Eur Heart J. 2020 May 14;41(19):1858
pubmed: 32227120
Heart Rhythm. 2020 Sep;17(9):1463-1471
pubmed: 32387246
Zhonghua Yi Xue Za Zhi. 2015 Jul 28;95(28):2258-63
pubmed: 26710947
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008662
pubmed: 32347743
Egypt Heart J. 2020 Jul 13;72(1):41
pubmed: 32661796
Eur Respir Rev. 2018 Oct 3;27(149):
pubmed: 30282634
Cardiol Clin. 2019 Nov;37(4):505-523
pubmed: 31587791
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Lancet. 2020 Mar 28;395(10229):1014-1015
pubmed: 32197108
Lancet Rheumatol. 2020 Aug;2(8):e474-e484
pubmed: 32835257
Open Forum Infect Dis. 2020 Jun 21;7(7):ofaa241
pubmed: 32671131
Eur Heart J. 2020 Jun 7;41(22):2109-2117
pubmed: 32498081
Rheumatology (Oxford). 2020 Dec 1;59(12):e147-e150
pubmed: 32968761
Clin Cardiol. 2020 Feb;43(2):99-107
pubmed: 31825114
Thromb Res. 2020 Jul;191:9-14
pubmed: 32353746
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
J Thromb Thrombolysis. 2020 Jul;50(1):72-81
pubmed: 32440883
Heart Rhythm. 2020 Sep;17(9):1439-1444
pubmed: 32585191
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Infect Dis Rep. 2020 May 13;12(2):8609
pubmed: 32913621
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Circulation. 2016 Jun 7;133(23):2314-33
pubmed: 27267538
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d
pubmed: 23824828
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687
pubmed: 32352535
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904
Ageing Res Rev. 2016 Mar;26:96-111
pubmed: 26835847
Chin Med J (Engl). 2020 May 5;133(9):1025-1031
pubmed: 32044814